Intravenous immunoglobulin for the treatment of childhood encephalitis
Encephalitis is a syndrome of neurological dysfunction due to inflammation of the brain parenchyma, caused by an infection or an exaggerated host immune response, or both. Attenuation of brain inflammation through modulation of the immune response could improve patient outcomes. Biological agents su...
Үндсэн зохиолчид: | Iro, M, Martin, N, Absoud, M, Pollard, A |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Cochrane Collaboration
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
-н: Hill, M, зэрэг
Хэвлэсэн: (2023) -
Childhood encephalitis in the United Kingdom - epidemiology, trends in hospital admissions and the role of intravenous immunoglobulin
-н: Iro, M
Хэвлэсэн: (2018) -
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
-н: Iro, MA, зэрэг
Хэвлэсэн: (2024) -
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
-н: Simon Nadel, зэрэг
Хэвлэсэн: (2023-11-01) -
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
-н: Mildred A Iro, зэрэг
Хэвлэсэн: (2024-04-01)